NCT00521430: Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease |
|
|
| Completed | N/A | 30 | RoW | anti-thymocyte globulin, busulfan, cyclosporine, fludarabine phosphate, methotrexate, methylprednisolone, allogeneic hematopoietic stem cell transplantation, peripheral blood stem cell transplantation | Asan Medical Center | Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Nonmalignant Neoplasm, Unspecified Adult Solid Tumor, Protocol Specific | 05/08 | 09/08 | | |
